Mr. Craig Milne reports

INNOVOTECH INC. SIGNS NATIONAL DISTRIBUTION AGREEMENT WITH HEALTHMARK TO BRING INNOVOTEST HAZARDOUS DRUG WIPE TESTING KITS TO PHARMACIES ACROSS CANADA

Innovotech Inc. has signed a distribution agreement with Healthmark Services Ltd., a coast-to-coast Canadian distributor of medical and pharmacy products, to distribute the company's InnovoTEST hazardous drug wipe testing kits nationally.

Under the agreement, Healthmark will offer InnovoTEST kits to its customers in hospital, community and long-term-care pharmacy across Canada. The two companies will also work together to support pharmacists through Healthmark's suite of services, helping pharmacy teams set up and maintain routine surface monitoring programs for hazardous drugs. The agreement also positions Innovotech to expand its sterility testing and environmental monitoring services with pharmacy compounding customers across Canada.

Pharmacists and pharmacy technicians who prepare and handle hazardous drugs, including many chemotherapy agents, can be exposed through contaminated work surfaces, often without any visible sign. Based on guidance from the National Association of Pharmacy Regulatory Authorities, routine surface monitoring is an increasingly important part of hazardous drug handling programs, allowing facilities to confirm that their containment and cleaning practices are working.

Innovotech launched InnovoTEST kits in August, 2026, to meet the need for simple, domestic surface monitoring. Clients collect surface samples using the supplied kit, return them for analysis at accredited Canadian facilities and receive a report of results. Keeping the analysis in Canada avoids cross-border shipping of samples and supports alignment with Canadian regulatory requirements.

Highlights of the agreement include:

• National reach: Healthmark has served the Canadian health care market since 1990, and supplies hospital, community and long-term-care pharmacies coast to coast.
• An all-Canadian solution: InnovoTEST kits are developed by Innovotech, distributed nationally by Healthmark and analyzed in accredited Canadian facilities, so samples never leave Canada.
• A natural fit with Healthmark's portfolio: InnovoTEST kits complement Healthmark's existing offerings in clean room and compounding equipment, protective equipment, quality and contamination control, and training and certification.
• Joint support for pharmacists: Innovotech and Healthmark will jointly support pharmacy customers in establishing and maintaining hazardous drug surface monitoring programs, from wipe sampling guidance and staff training through to interpreting InnovoTEST results.
• Agreement terms: Healthmark has been appointed the exclusive distributor of InnovoTEST kits across Canada for an initial three-year term, effective immediately.

"Hazardous drug contamination on surfaces is invisible, and pharmacists need a practical way to check that their safety practices are working," said Craig Milne, chief executive officer of Innovotech. "Healthmark already sits at the centre of how many Canadian pharmacies equip and run their compounding areas. Putting InnovoTEST kits into their catalogue, backed by their service team and our Canadian laboratory analysis, gives pharmacists across the country an easy, domestic way to monitor their environment and protect their staff. For Innovotech, it is a meaningful step in building a recurring testing revenue stream from the pharmacy and hospital market."

"Ensuring a safe environment for pharmacy professionals is a priority, particularly when handling hazardous drugs," said Michael Bussieres, senior vice-president at Healthmark. "At Healthmark, we're committed to providing our customers with practical solutions that support both safety and regulatory compliance. InnovoTEST is a natural complement to our existing portfolio of compounding and contamination control solutions, and we're pleased to partner with another Canadian company to make this important testing service more accessible to pharmacies across the country."

InnovoTEST kits are available for order exclusively through Healthmark. Health care facilities interested in testing panels, sampling strategies or turnaround times can contact Healthmark or Innovotech. Product information, along with a link to order through Healthmark, will be available at the Innovotech website.

About Innovotech Inc.

Innovotech is a leading life science service and technology company specializing in contract research, analytical and microbial testing within regulated health care markets. The company is a recognized leader in biofilm science and anti-microbial testing and provides advanced laboratory services supporting medical device, pharmaceutical and industrial product development. Innovotech combines deep scientific expertise with proprietary methodologies and products, including its widely used MBEC assay platform for high-throughput anti-microbial and antibiotic testing. Operating through ISO-certified and GMP-accredited laboratories, Innovotech supports clients across multiple sectors and geographies, delivering reliable, decision-enabling data aligned with regulatory expectations such as those of the U.S. Food and Drug Administration and Health Canada.

We seek Safe Harbor.